| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hypoalphalipoproteinemias | D052456 | 5 associated lipids |
| Renal Artery Obstruction | D012078 | 8 associated lipids |
| Death, Sudden, Cardiac | D016757 | 12 associated lipids |
| Blood Platelet Disorders | D001791 | 12 associated lipids |
| Cerebral Hemorrhage | D002543 | 13 associated lipids |
| Polycythemia Vera | D011087 | 13 associated lipids |
| Atrial Fibrillation | D001281 | 16 associated lipids |
| Albuminuria | D000419 | 18 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
| Cerebrovascular Disorders | D002561 | 25 associated lipids |
11-dehydro-TXB2
11-dehydro-txb2 is a lipid of Fatty Acyls (FA) class. 11-dehydro-txb2 is associated with abnormalities such as endothelial dysfunction, Risk factor, cardiovascular, Acute coronary syndrome, thrombocytosis and Chronic ischemic heart disease NOS. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and Lipid Peroxidation. The associated genes with 11-dehydro-TXB2 are PTGS2 gene.
Cross Reference
Introduction
To understand associated biological information of 11-dehydro-TXB2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 11-dehydro-TXB2?
11-dehydro-TXB2 is suspected in endothelial dysfunction, Risk factor, cardiovascular, Acute coronary syndrome, thrombocytosis, Chronic ischemic heart disease NOS, Diabetes Mellitus and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 11-dehydro-TXB2
PubChem Associated disorders and diseases
What pathways are associated with 11-dehydro-TXB2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 11-dehydro-TXB2?
There are no associated biomedical information in the current reference collection.
What functions are associated with 11-dehydro-TXB2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 11-dehydro-TXB2?
There are no associated biomedical information in the current reference collection.
What genes are associated with 11-dehydro-TXB2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with 11-dehydro-TXB2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with 11-dehydro-TXB2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Satoh K et al. | Plasma 11-dehydrothromboxane B2: a reliable indicator of platelet hyperfunction in patients with ischemic stroke. | 1991 | Acta Neurol. Scand. | pmid:2017905 |
| Bridges AB et al. | Circadian variation of endothelial cell function, red blood cell deformability and dehydro-thromboxane B2 in healthy volunteers. | 1991 | Blood Coagul. Fibrinolysis | pmid:1932530 |
| Van Geet C et al. | Possible platelet contribution to pathogenesis of transient neonatal hyperammonaemia syndrome. | 1991 | Lancet | pmid:1670726 |
| Takayama K et al. | Changes in endothelial vasoactive substances under recombinant human erythropoietin therapy in hemodialysis patients. | 1991 Jul-Sep | ASAIO Trans | pmid:1836334 |
| Landolfi R et al. | Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo. | 1992 | Blood | pmid:1327286 |
| Tohgi H et al. | Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin. | 1992 | Stroke | pmid:1412574 |
| Kumlin M et al. | Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics. | 1992 | Am. Rev. Respir. Dis. | pmid:1320824 |
| Reinke M | Monitoring thromboxane in body fluids: a specific ELISA for 11-dehydrothromboxane B2 using a monoclonal antibody. | 1992 | Am. J. Physiol. | pmid:1590375 |
| Riutta A et al. | Solid-phase extraction of urinary 11-dehydrothromboxane B2 for reliable determination with radioimmunoassay. | 1992 | Anal. Biochem. | pmid:1519756 |
| Rebuzzi AG et al. | Importance of reperfusion on thromboxane A2 metabolite excretion after thrombolysis. | 1992 | Am. Heart J. | pmid:1539506 |